mytide Therapeutics Revenue and Competitors

Boston, MA USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • mytide Therapeutics's estimated annual revenue is currently $1M per year.(i)
  • mytide Therapeutics's estimated revenue per employee is $77,500

Employee Data

  • mytide Therapeutics has 13 Employees.(i)
  • mytide Therapeutics grew their employee count by -50% last year.

mytide Therapeutics's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Founder and CTOReveal Email/Phone
3
Director, Manufacturing and OperationsReveal Email/Phone
4
Senior Software EngineerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$12.7M82-45%$107.3MN/A
#2
$0.2M1-50%N/AN/A
#3
$6.2M4021%N/AN/A
#4
$42.2M2184%$165MN/A
#5
$14.6M94-37%$312.8MN/A
#6
$0.3M2-67%N/AN/A
#7
$235M366-5%$340.9MN/A
#8
$56M289-7%$7.6MN/A
#9
$4.7M6136%N/AN/A
#10
$2M138%N/AN/A
Add Company

What Is mytide Therapeutics?

mytide is a groundbreaking technology startup focused on accelerating peptide therapeutics R&D. We are a multi-disciplinary team of engineers, biochemists, and computer scientists who have created the first company to take a technologically advanced approach to solving long-standing challenges in both peptide synthesis and purification. mytide's fully automated peptide manufacturing technology, coupled with predictive analytics and machine learning, is challenging decades-old paradigms to enable cost-efficient research and development, therapeutic manufacturing and therapeutic discovery. Our aim is to accelerate the discovery and development of life-saving peptide therapeutics for serious conditions ranging from metabolic conditions to cancer to inflammatory disorders to infectious diseases.

keywords:N/A

N/A

Total Funding

13

Number of Employees

$1M

Revenue (est)

-50%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.1M13N/AN/A
#2
$2.4M13N/AN/A
#3
$2M13-24%N/A
#4
$1M13-52%$10.3M
#5
$0.8M13-67%$2.2M